The Role of Gene Expression in Body Functioning

Understanding Gene Splicing

The expression of genes encoded in DNA plays a crucial role in the functioning of our body. However, the complexity of biological processes requires more proteins than the number of genes available. Cells navigate this limitation through a process known as splicing, which involves cutting genes in various ways at different times to create diverse products.

Research Findings on Alzheimer’s Disease

Study Overview

Recent research indicates that improper gene splicing may contribute to the progression of Alzheimer’s disease. A study published in *Nature Genetics* by Raj and colleagues explores alternate splicing in patients diagnosed with Alzheimer’s.

Investigation Methodology

Prior studies suggested a potential link between alternate splicing of specific genes and the advancement of Alzheimer’s. To confirm these hypotheses, the researchers analyzed DNA sequences and expression patterns in the brains of 450 individuals, both with and without Alzheimer’s and other forms of dementia.

Key Discoveries

The investigation revealed 53,251 alternate splicing sequences from 16,557 genes in individuals who had an Alzheimer’s diagnosis at the time of death. Notably, 82 of these splicing sequences from 67 genes were connected to nervous system pathologies, plaque formation, and other elements associated with Alzheimer’s progression.

Implications for Future Research

Raj and colleagues identified that certain genes are affected in consistent patterns linked to Alzheimer’s progression. Furthermore, these alternate splicing patterns influence genes known to be associated with Alzheimer’s risk. Future research is necessary to further elucidate the mechanisms behind alternate splicing. There is also the possibility that this process could play a role in other diseases.

Potential for Treatment

This study highlights a significant new target for treatments aimed at preventing the onset or progression of Alzheimer’s disease. Combining this approach with technologies like CRISPR, which can target specific gene segments, may lead to innovative therapeutic strategies.

Reference

Raj et al. 2018. Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer’s disease susceptibility. *Nature Genetics*.